Home product Job offers Contact imprint Data protection Welcome to Norbitec, the manufacturer of erythropoietin (Epoetin zeta). who we are Norbitec GmbH was founded in 2003 as a joint venture and is a company of BIOCEUTICALS Arzneimittel AG, a holding company of STADA Arzneimittel AG (www.stada.de) and Nordmark Pharma GmbH (www.nordmark-pharma.de). What we do The focus of our work is the production of erythropoietin (Epoetin zeta), a biotechnologically produced active ingredient for the treatment of anemia. The central European approval for Silapo and Retacrit with the active ingredient Epoetin zeta was granted by the European Commission in December 2007. Current Job offers